PGE2-treated macrophages inhibit development of allergic lung inflammation in mice
Open Access
- 1 March 2016
- journal article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 100 (1) , 95-102
Abstract
In healthy lungs, many macrophages are characterized by IL-10 production, and few are characterized by expression of IFN regulatory factor 5 (formerly M1) or YM1 and/or CD206 (formerly M2), whereas in asthma, this balance shifts toward few producing IL-10 and many expressing IFN regulatory factor 5 or YM1/CD206. In this study, we tested whether redressing the balance by reinstating IL-10 production could prevent house dust mite-induced allergic lung inflammation. PGE2 was found to be the best inducer of IL-10 in macrophages in vitro. Mice were then sensitized and challenged to house dust mites during a 2 wk protocol while treated with PGE2 in different ways. Lung inflammation was assessed 3 d after the last house dust mite challenge. House dust mite-exposed mice treated with free PGE2 had fewer infiltrating eosinophils in lungs and lower YM1 serum levels than vehicle-treated mice. Macrophage-specific delivery of PGE2 did not affect lung inflammation. Adoptive transfer of PGE2-treated macrophages led to fewer infiltrating eosinophils, macrophages, (activated) CD4+, and regulatory T lymphocytes in lungs. Our study shows that the redirection of macrophage polarization by using PGE2 inhibits development of allergic lung inflammation. This beneficial effect of macrophage repolarization is a novel avenue to explore for therapeutic purposes.Keywords
Funding Information
- BNM (3.2.10.056)
This publication has 35 references indexed in Scilit:
- PGE2 Induces Macrophage IL-10 Production and a Regulatory-like Phenotype via a Protein Kinase A–SIK–CRTC3 PathwayThe Journal of Immunology, 2013
- Characterization of Macrophage Phenotypes in Three Murine Models of House-Dust-Mite-Induced AsthmaMediators of Inflammation, 2013
- Phenotypic characterization of lung macrophages in asthmatic patients: Overexpression of CCL17Journal of Allergy and Clinical Immunology, 2012
- PGE2 receptor (EP4) agonists: Potent dilators of human bronchi and future asthma therapy?Pulmonary Pharmacology & Therapeutics, 2012
- Human asthma phenotypes: from the clinic, to cytokines, and back againImmunological Reviews, 2011
- More alternative activation of macrophages in lungs of asthmatic patientsJournal of Allergy and Clinical Immunology, 2011
- MacrophagesAmerican Journal of Respiratory Cell and Molecular Biology, 2010
- Alternative Activation of Macrophages: Mechanism and FunctionsImmunity, 2010
- Selective inhibition of T cell proliferation but not expression of effector function by human alveolar macrophagesThorax, 1997
- Stimulation of ‘irritant’ receptors and afferent C-fibres in the lungs by prostaglandinsNature, 1976